(新浪医药编译/David)
文章参考来源:
1、Boehringer inks pact with Domain for GPCR neurology drugs
2、Domain Therapeutics signs a multi-target research collaboration and license agreement with Boehringer Ingelheim on G Protein-Coupled Receptors (GPCRs) for Central Nervous System Disorders
3、http://www.domaintherapeutics.com/research-and-technology/dtect-all.html
*声明:本文由入驻新浪医药新闻作者撰写,观点仅代表作者本人,不代表新浪医药新闻立场。